Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation
暂无分享,去创建一个
Jin Young Kim | Jong Shin Yoo | Young-Ki Paik | Hyun Joo An | Hyun Kyoung Lee | Yong-Sam Kim | Jeong-Heon Ko | J. Ko | J. Kim | J. Yoo | Y. Paik | Ju Yeon Lee | Ki Na Yun | H. An | Heeyoun Hwang | Jae Han Kim | Gun Wook Park | Heeyoun Hwang | Young Hee Ahn | Eun Sun Ji | Kwang Hoe Kim | Hoi Keun Jeong | E. Ji | Hyun kyoung Lee | Yong-Sam Kim | Young Hee Ahn | Jae Han Kim
[1] Xianghuo He,et al. SERPINA5 inhibits tumor cell migration by modulating the fibronectin‐integrin β1 signaling pathway in hepatocellular carcinoma , 2014, Molecular oncology.
[2] Aneeka M Hancock,et al. Glycoproteomics in neurodegenerative diseases. , 2010, Mass spectrometry reviews.
[3] R. Dwek,et al. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. , 2007, Glycobiology.
[4] Chen-Chun Chen,et al. MAGIC: an automated N-linked glycoprotein identification tool using a Y1-ion pattern matching algorithm and in silico MS² approach. , 2015, Analytical chemistry.
[5] Serenus Hua,et al. Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures. , 2013, Analytical chemistry.
[6] S. Fukushima,et al. alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers. , 2004, The American journal of pathology.
[7] S. Hanash,et al. The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome , 2012, Nature Biotechnology.
[8] L. Drahos,et al. High-performance liquid chromatography coupled to mass spectrometry methodology for analyzing site-specific N-glycosylation patterns. , 2012, Journal of chromatography. A.
[9] H. Kuwano,et al. Development of a Novel System for Mass Spectrometric Analysis of Cancer-Associated Fucosylation in Plasma α 1-Acid Glycoprotein , 2013, BioMed research international.
[10] Yong J. Kil,et al. Byonic: Advanced Peptide and Protein Identification Software , 2012, Current protocols in bioinformatics.
[11] Obi L Griffith,et al. Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes. , 2012, Cancer research.
[12] S. Nishimura,et al. Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma. , 2011, Journal of proteomics.
[13] Scott R. Kronewitter,et al. The development of retrosynthetic glycan libraries to profile and classify the human serum N‐linked glycome , 2009, Proteomics.
[14] N. Edwards,et al. Site-specific Glycoforms of Haptoglobin in Liver Cirrhosis and Hepatocellular Carcinoma* , 2013, Molecular & Cellular Proteomics.
[15] Salvatore Panico,et al. Prediagnostic plasma testosterone, sex hormone‐binding globulin, IGF‐I and hepatocellular carcinoma: Etiological factors or risk markers? , 2014, International journal of cancer.
[16] Heba F Pasha,et al. Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma. , 2012, Clinical biochemistry.
[17] R. Aebersold,et al. A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* , 2011, Molecular & Cellular Proteomics.
[18] Radoslav Goldman,et al. Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search. , 2013, Journal of proteome research.
[19] Nicole Rusk. Causal mutations in a haploid landscape , 2011, Nature Methods.
[20] S. Hanash,et al. Towards an integrated proteomic and glycomic approach to finding cancer biomarkers , 2009, Genome Medicine.
[21] Hoguen Kim,et al. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma. , 2012, Journal of proteomics.
[22] Haixu Tang,et al. Label-free glycopeptide quantification for biomarker discovery in human sera. , 2014, Journal of proteome research.
[23] Suh-Yuen Liang,et al. Sweet-Heart - an integrated suite of enabling computational tools for automated MS2/MS3 sequencing and identification of glycopeptides. , 2013, Journal of proteomics.
[24] M. Tajiri,et al. Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. , 2004, Analytical chemistry.
[25] Benny Zee,et al. Application of Classification Tree and Neural Network Algorithms to the Identification of Serological Liver Marker Profiles for the Diagnosis of Hepatocellular Carcinoma , 2001, Oncology.
[26] Yusuke Nakamura,et al. Quantitative structural characterization of local N-glycan microheterogeneity in therapeutic antibodies by energy-resolved oxonium ion monitoring. , 2012, Analytical chemistry.
[27] Tsung-Hsien Pu,et al. Novel LC-MS² product dependent parallel data acquisition function and data analysis workflow for sequencing and identification of intact glycopeptides. , 2014, Analytical chemistry.
[28] H. Shiraha,et al. Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.
[29] J. Kim,et al. QUANTITATIVE MASS SPECTROMETRIC ANALYSIS OF GLYCOPROTEINS COMBINED WITH ENRICHMENT METHODS , 2014, Mass spectrometry reviews.
[30] C. Van Steenkiste,et al. Alteration of protein glycosylation in liver diseases. , 2009, Journal of hepatology.
[31] M. Raftery,et al. Detection and Characterization of Low Abundance Glycopeptides Via Higher-Energy C-Trap Dissociation and Orbitrap Mass Analysis , 2011, Journal of The American Society for Mass Spectrometry.
[32] I. Rudan,et al. Comparative Performance of Four Methods for High-throughput Glycosylation Analysis of Immunoglobulin G in Genetic and Epidemiological Research , 2014, Molecular & Cellular Proteomics.
[33] E. Go,et al. Label-free quantitation: A new glycoproteomics approach , 2009, Journal of the American Society for Mass Spectrometry.
[34] Shisheng Sun,et al. Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera , 2013, Proteomics.
[35] Kit S. Lam,et al. A Serum Glycomics Approach to Breast Cancer Biomarkers*S , 2007, Molecular & Cellular Proteomics.
[36] A. Tessitore,et al. Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors , 2013, International journal of proteomics.
[37] Haixu Tang,et al. Computational framework for identification of intact glycopeptides in complex samples. , 2014, Analytical chemistry.
[38] Jonathan C Trinidad,et al. N- and O-Glycosylation in the Murine Synaptosome* , 2013, Molecular & Cellular Proteomics.
[39] Chen Li,et al. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. , 2010, Journal of proteome research.
[40] Hongyang Wang,et al. Development of Glycoprotein Capture-Based Label-Free Method for the High-throughput Screening of Differential Glycoproteins in Hepatocellular Carcinoma* , 2011, Molecular & Cellular Proteomics.
[41] Nichollas E. Scott,et al. Site-specific glycan-peptide analysis for determination of N-glycoproteome heterogeneity. , 2013, Journal of proteome research.
[42] Florian Gnad,et al. Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints , 2010, Cell.
[43] Bin Gao,et al. The complement system in liver diseases. , 2006, Cellular & molecular immunology.